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Abstract
Background: Risk of cardiovascular disease (CVD) can be increased by single-nucleotide polymorphisms (SNPs) in
the 9p21 region of the genome. However, observational studies have shown that the deleterious effect of 9p21
SNPs on CVD might be offset by consuming a diet rich in fresh fruits and vegetables. This association may be
driven by diet-influenced modifications in epigenetic and gene expression profiles. In this pilot study, we aimed
to: i. test the feasibility of provision of a ‘Prudent’ and ‘Western’ diet outside of a specialized clinic, ii. assess the
impact of each diet on cardiovascular risk factors.
Methods: A single centre, parallel two-arm, pilot randomized controlled trial (RCT) with food provision was
conducted in a university teaching hospital outpatient clinic (McMaster university, Hamilton, ON, Canada). The
aim was to recruit 80 participants, which allowed for a 10 % dropout. The actual study consisted of 84 apparently
healthy participants (69 % women, 18 to 77 years) at low cardiovascular risk. Participants were randomly assigned
to follow one of two weight-maintaining diets: ‘Prudent’ or ‘Western’ for 2-weeks. The Prudent diet provided
<7 % of energy as saturated fat, a polyunsaturated: saturated fat ratio of 1.0, and increased fibre, fruits and
vegetables. The Western diet was high in processed foods and sugar, with a moderate quantity of fruit and
vegetables. All food was provided. Feasibility outcomes included time to recruitment and retention of
participants, successful provision of foods, along with adherence to and palatability of the assigned diets.
Secondary outcomes were changes in total cholesterol, low density lipoprotein cholesterol (LDL-C), systolic blood
pressure (SBP), and diastolic blood pressure (DBP) to obtain variance and estimates of effect sizes to inform the
sample size calculation for a definitive trial.
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Results: Recruitment was undertaken over 2 periods spanning 8 months between May-December, 2012.
Response rates were high, with 228 screened participants yielding 84 randomized participants. Eight-two of 84
(98 %) of participants completed the intervention. Self-reported adherence to the diets was excellent (>92 % of
provided food consumed). The Prudent diet was 48 % more palatable than the Western diet (P < 0.05). Participants
receiving the Prudent diet showed a trend toward reduced systolic (-4 mmHg; P = 0.10) and diastolic (-3 mmHg;
P = 0.07) blood pressure, and total cholesterol (-0.24 mmol/L; P = 0.08), compared to individuals receiving the Western
diet. Data collection from all randomized participants was completed within 18 months.
Conclusions: Recruitment, and retention of apparently healthy, normotensive adults into a feeding study for a 2-week
duration is feasible outside of specialized dietary clinic, and modest diet-related changes in biomarkers begin to appear
after two weeks.
Trial registration: NCT01658137 (clinicaltrials.gov).
Keywords: Nutrition, Randomized controlled trial, Pilot study, Feasibility
Background
The majority of cardiovascular disease (CVD) is explained
by conventional risk factors including cigarette smoking,
abnormal lipid levels, high blood pressure, obesity, dia-
betes, and health behaviours including dietary intake,
physical activity, and psychosocial stressors [1]. Genetic
factors contribute to the development of these risk factors,
and directly to CVD through other novel pathways. Since
the advent of high throughput chip-based genotyping,
more than 45 genetic variants have been found to be asso-
ciated with myocardial infarction (MI) [2, 3].
The most robust genetic variant that has been consist-
ently associated with MI and other forms of arterial disease
is the 9p21 variant. This variant, located on chromosome 9,
is common in the population, with 50 % of people carrying
one copy of the risk allele and an additional 25 % of the
population carrying two copies of the risk allele. Compared
to individuals with no risk allele, the risk of MI with one
copy of the risk allele is 15-20 % higher, and the risk with
two copies of the risk allele is 20-40 % higher [4]. Further,
the risk associated with two versus one risk allele is aug-
mented (+14 %) in younger individuals (<55 yrs) relative to
older individuals [5]. To date the exact mechanism by
which 9p21 variants increase the risk of MI is uncertain;
however, 9p21 variants consistently appear to influence
the expression of antisense non-coding RNA in the INK4
locus (ANRIL), which plays a role in regulating expression
of cylcin-dependent kinase inhibitor 2A (CDKN2A) and
cylcin-dependent kinase inhibitor 2B (CDKN2B), which
may influence vascular integrity and atherogenesis [6, 7].
Recently, we made the observation that among carriers of
the risk allele, the associated risk of MI may be negated
among individuals that report consuming a diet high in
fruits and vegetables — suggesting a gene-diet interaction
[8]. However, the mechanisms by which diet alters the
genomic activity of 9p21 are not known, and the epigen-
etic responsiveness of the region to acute changes in diet
has not been studied.
Improvements in total and low-density lipoprotein
(LDL) cholesterol have been reported after 2- to 2.5-
weeks of increased vegetable, fruit, and nut consumption
or increased polyunsaturated or monounsaturated fats in
healthy men and women [9, 10]. Major dietary factors
that affect blood pressure (sodium, potassium, and dietary
patterns) have each reduced BP within four weeks with
the biggest drop typically seen after two weeks [11, 12]. In
preparation for a study to understand the genetic and
epigenetic mechanisms underlying these epidemiologic
findings, we enrolled two groups of individuals, young
and older (i.e., < or ≥ 50 years) into the Diet and Genetic
Intervention (DIGEST) pilot study. In this report, we de-
scribe the study design, report on the feasibility of providing
food to free-living participants outside of a specialty dietary
clinic, and assess the magnitude of changes in markers of
cardiovascular risk and inflammation that occur in re-
sponse to a “Prudent” versus a “Western” diet administered
to individuals < or ≥ 50 years of age after 2-weeks.
Methods
Study design
DIGEST is an investigator-initiated efficacy trial to
understand the genetic and epigenetic mechanisms
underlying the role of 9p21 genetic variants in modulating
diet-associated cardiovascular risk. It is a parallel-2-arm
randomized controlled trial with food provision to compare
the effects on blood pressure (BP), inflammatory markers,
lipids, gene expression and DNA methylation between a
“Western” diet and a “Prudent” diet. The study took place
at a university campus (McMaster University, Hamilton,
ON) and teaching hospital (McMaster University Medical
Centre). Eligibility was determined through telephone
screening. Eligible participants were randomized to one of
two diets (Western or Prudent) and all food was provided
for 2 weeks. The study was approved by the Hamilton Inte-
grated Research Ethics Board (May 2012), and the protocol
was registered with clinicaltrials.gov (NCT01658137). We
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have adhered to CONSORT guidelines (http://www.consort-
statement.org/) for the reporting of clinical trials.
Recruitment
Participants were recruited through flyers posted on-cam-
pus, in-hospital, and at various places in close proximity to
the University campus; as well as monthly runs of advertise-
ments in a local newspaper (Hamilton Spectator, Hamilton,
ON). Recruitment was carried out by study coordinators in
consultation with the study principal investigator
(R.J.dS., S.S.A.) in two phases—the first phase (May-October
2012) targeted a population of generally healthy volunteers
under the age of 50, and a second phase (October - Decem-
ber 2012) aimed at a population of generally healthy volun-
teers aged 50 or older. Enrolled participants were
encouraged to refer spouses/partners, or other interested
friends. In total, 228 participants inquired and were
screened which yielded 84 randomized participants.
Eligible participants
Eligible participants were community-dwelling men and
women willing to consume all foods in the Prudent and
Western diets that were between the ages of 18 and 80
with a body-mass index (BMI) <45 kg/m2 and were free
of cancer, renal and liver disease, and not taking medica-
tions for diabetes, hyperlipidemia, or hypertension. The
full inclusion and exclusion criteria are presented in
Table 1. Prior to enrolment, each participant read an
abridged version of the study protocol and was provided
an opportunity to ask questions of the study staff to en-
sure informed consent to participate in the study, in-
cluding storage of blood, and genetic testing.
Study protocol
The study was a parallel-2-arm randomized controlled
trial carried out between June 2012 and November 2013.
Participants were seen at a screening visit 1- 2 weeks
prior to beginning the dietary intervention. If eligibility
criteria were met, subjects were randomized to either a
“Prudent” low-saturated fat diet rich in fruits and vegeta-
bles, or a “Western” diet emphasizing processed foods.
Each diet lasted for 2-weeks. All foods were provided.
Body weight and percent body fat by bioelectrical im-
pedance (Digital Weight Scale, tanita.com) were mea-
sured weekly, and whole blood samples were obtained at
baseline and 2-weeks post-randomization. At each clinic
visit, participant blood pressure was measured three times
in the non-dominant arm using an automated mercury
sphygmomanometer. Seven-day diet histories were ob-
tained for the week prior to beginning the intervention.
Completed menu checklists were returned after 1 and
2 weeks of treatment and checked by study personnel
(M.N., S.K., R.J.dS.), who also recorded the participant’s
previous week’s exercise and ensured it was constant over
the study period.
At each visit, participants recorded their overall feeling
of satiety using a 9-point bipolar semantic scale in
which -4 was excessively hungry, 0 was neutral, and +4
was uncomfortably full; gas and bloating on a 3-point scale
in which -1 was less than usual, 0 was as usual, and +1
was more than usual; and palatability of the diet on a scale
of 1 (not palatable) to 10 (highly palatable) [13]. Daily
bowel habits were also recorded. Each week, participants
were provided with a 7-day menu plan on which they
checked off each item as eaten.
A simple randomization list, stratified by age (<50
and ≥50 years) was created using a random number
generator by a student who did not see participants.
Opaque envelopes containing a treatment assignments
were provided to study personnel responsible for providing
food and seeing participants. Study personnel responsible
for enrolling participants were not blinded to the partici-
pant’s diet because they also purchased the food for each
participant and reviewed the diet records at each visit. Staff
responsible for the laboratory analysis were blinded to
treatment and received samples labeled with bar codes.
Participant compensation
Participants were provided with parking vouchers (up to
$20 CAD) to attend each of the screening, and on-study
Table 1 Inclusion and exclusion criteria
Inclusion criteria
• Willing and able to provide informed consent
• Willing and able to attend 3 clinic visits
• Willing and able to eat all foods on Prudent or Western diets
• Age ≥18 years of age
Exclusion criteria (self reported)
• Alcoholic beverage intake >14 drinks/week
• Use of food or nutritional supplements that cannot be discontinued
• Current use of anti-inflammatory medications that cannot be discontinued
• Current use of anti-hypertensive medications that cannot be discontinued
• Current use of anti-cholesterol medications that cannot be
discontinued
• Previous diagnosis of cardiovascular disease or cardiovascular event
within past year
• Body-mass-index ≥45 kg/m2
• High blood pressure (or on anti-hypertensive medications)
• Abnormal blood lipids (or on lipid-modifying medications)
• Diabetes mellitus (FPG≥ 7.0) or impaired fasting glucose (fasting
glucose 6.1 to 6.9)
• Renal insufficiency or disease
• Hepatitis or Jaundice
• Liver disease
• Tuberculosis
• HIV/AIDS
• Active malignancy or cancer treatment within past 1 year
• Inflammatory bowel disease, malabsorptive states
• Current asthma (use of bronchodilator ≥1 time in past month)
• Any chronic disease likely to influence adherence to diet or
participation in study
• Current or planned pregnancy during term of study
• Current use of oral contraceptives or hormone replacement therapy
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visits. All food was provided at no cost to the partici-
pants. No additional compensation was provided.
Diets
Diet development
Meal plans were designed by a registered dietitian and
nutrition researcher (R.d S. and A.M.). Seven-day menu
plans were provided to participants, who prepared their
own meals with their own choices of low-caloric condi-
ments/seasonings (e.g. ketchup, salt, pepper, spices, etc.).
Cooking fats (e.g. plant oils and butter) were provided
and encouraged as per diet assignment. Representative
menu plans for the Western and prudent diets are shown
in Additional file 1: Table S1.
The “Prudent” diet was based on the DASH diet, which
encourages vegetables, fruits, whole grains, fat-free or
low-fat dairy products, fish, poultry, beans, nuts, and
vegetable oils; and limited foods high in saturated fat (
such as fatty meats, full-fat dairy products, and tropical
oils such as coconut, palm kernel, and palm oils) and
sugar-sweetened beverages and sweets [14]. The Prudent
diet achieved a low saturated fat content (<7 %) by includ-
ing small amounts of lean animal products, low-fat dairy,
plant proteins, and maintained a polyunsaturated:satu-
rated fat ratio (P:S) of 1.0 by use of unsaturated vegetable
oils. At least 6 cup equivalents of fruits and vegetables per
day were provided; and overall, the diet provided 40 g fiber
per 2000 kilocalories (kcal) from whole grains, nuts, fruits
and vegetables.
The “Western” diet was characterized by a higher in-
take of red and processed meat, butter, high-fat dairy
products, eggs, refined grains, processed potato products
(such as french fries and hash browns), and high-sugar
drinks and sweets [15]. This diet achieved a high satu-
rated fat (≈13 %) content with a P:S ratio of 0.5 by
providing fats as butter, in ground beef products, full-
fat dairy/ice cream/cheese; and was kept low in dietary
fibre (<14 g/2000 kcal), by providing refined grains,
and <3 cup equivalents of fruits and vegetable/d mainly
from juices.
Energy balance
All diets were designed to be weight-maintaining; and
7-day meal plans were developed and provided to par-
ticipants at levels of 1600, 1800, 2100, 2300, 2500,
2700, 3000, and 3200 kcal/d. Energy requirements were
estimated at the screening visit using the Harris-
Benedict equation, multiplied by an appropriate activity
factor for each individual [16]. Energy requirements
were reassessed at the week 1 visit based on measured
weight change from baseline and diets were adjusted by
adding or reducing the amount of foods to achieve
weight stability.
Food provision
All foods (except coffee, tea, and condiments) were pur-
chased from a local supermarket (Fortino’s, Hamilton,
ON) and provided to participants. The first hamper was
provided at the randomization visit (week 0), and a “top
up” as needed at week 1. Because our outpatient clinic
does not have cold storage facilities for food, participants
obtained their foods in one of three ways: 1) home deliv-
ery, in which a member of the research team or student
volunteer purchased the foods and delivered them to the
participant’s home at a mutually-convenient time; 2) in-
store pick-up, in which a member of the research team
or student volunteer purchased the foods from a local
supermarket and the participant met the staff member
at the store to pick up the foods; or 3) in-clinic pick-up,
in which a member of the research team or student vol-
unteer purchased the food in the hour preceding the
participant’s study visit, and provided food to the partici-
pant at his/her clinic visit.
Lipid and inflammatory marker analysis
Fasting serum samples were collected at weeks 0 and 2, and
stored in liquid nitrogen (-160 °C) until the end of study,
when they were analyzed for inflammatory and lipid markers
at the Clinical Research and Clinical Trials Laboratory
(CRCTL; Population Health Research Institute, Hamilton,
ON). Total- and high-density lipoprotein-cholesterol (TC
and HDL-C), and triglycerides (TG) were measured by timed
end-point method under standard laboratory protocols using
the Beckman Coulter Unicel®DxC600 Synchron® Clinical
System and reagents (Beckman, California); non-HDL-C was
calculated as TC minus HDL-C.
Additional sample collection
Participants consented to having additional fasting ven-
ous whole blood samples drawn and provided spot urine
samples for future genetic, epigenetic, and metabolomic
studies. A spot urine has been shown to provide accur-
ate measures of sodium and potassium intake during the
previous 24-hours when validated against 24-hour urine
collections. Four 1 mL aliquots each of blood and urine
were stored in -70 °C freezers at CRCTL.
Statistical analyses
Results in text are presented as mean (SD) unless other-
wise noted. Where values were measured at both base-
line and follow-up, the primary method of analysis for
between-treatments comparisons for all continuous
outcomes was an analysis of covariance, with the week
2 value as the outcome variable, diet assignment as the
independent variable (main effect), and baseline value, age,
and sex as covariates to reduce the impact of confounding
by imbalance in these factors between randomized groups.
A 2-tailed paired t-test was used to assess the significance
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of within-treatment unadjusted changes from baseline.
Means of continuous variables which were not measured
at baseline (i.e. adherence, or intervention dietary intake)
were compared with independent samples t-test. The
unstandarized beta-coefficient from linear regression
models were used to describe the association between
changes in diet and changes in outcome variables
where stated. The significance of between-treatment
differences in proportions of categorical variables, i.e.
symptom reports, was assessed with Fisher’s exact test.
In order to avoid type-2 errors at this exploratory stage,
we did not correct for multiple testing. For this pilot study,
statistical tests yielding a nominal P < 0.05 were consid-
ered statistically significant; and those at 0.05 < P <0.10 are
reported as “trends”. Analyses of adherence, anthropomet-
ric, symptom and biomarker data were conducted using
linear models in SAS version 9.4 (SAS Institute, Cary,
NC, USA).
Power and sample size considerations
The secondary aim of this study was to obtain data on
changes in genetic and epigenetic marks and cardiovas-
cular risk factors in response to a diet intervention to
aid in the design of a future definitive trial [9, 10].
Results
Feasibility
Recruitment and retention
In total, 228 participants were telephone screened, yield-
ing 84 enrolled adults (58 women and 26 men) with a
mean age of 43.9 years (range: 18 to 77 years) and BMI
of 25.6 kg/m2 (range 19.3 to 44.8 kg/m2). We were re-
quired to screen approximately 3 interested participants
per successful enrolment. Baseline demographic charac-
teristics, cardiovascular risk factors (Table 2) and diet
profiles (Table 3) of these participants were comparable
between the two randomized arms, with the exception
that men assigned to the Western diet had higher non-
HDL-C (3.95 [0.73] vs. 2.98 [0.75] mmol/L; P < 0.003;
Table 2). Two participants, one from each diet assign-
ment withdrew during the first week of the study due to
difficulties following the assigned diet. Eighty-two of 84
participants completed the study (98 %) (Fig. 1).
Adherence
For the majority of participants, adherence was excellent
as assessed from completed diet checklists. 74 of 84 par-
ticipants (88.1 %) returned a completed 7-day food rec-
ord at baseline, and both food checklists at weeks 1 and
2. When expressed as the percentage of prescribed calo-
ries recorded as eaten, adherence was 99.7 % on the
Western diet and 92.9 % on the Prudent diet, according
to self-reported checklists (Table 4). The lower percentage
of provided foods reported as consumed on the Prudent
diet amounted to a net 157 kcal/d deficit compared with
the Western diet (P = 0.042), but this did not result in a sig-
nificantly different change in body weight over the 2-weeks.
Those assigned to the Prudent diet reported ≈ 7-cup
equivalent servings of fruits and vegetables per 2,000 kcal/
day, with higher intakes of protein, carbohydrate, dietary
fibre, vitamin C, potassium, and magnesium; and lower
intakes of total and saturated fat, dietary cholesterol, and
sodium than those assigned to the Western diet, who re-
ported <2 cup equivalent servings of fruits and vegetables
per 2000 kcal/day (Table 4). Most participants made use of
at least two of three food provision options (i.e. delivery, in-
store pick-up, or clinic pick-up) during the study.
Symptoms and palatability
The mean palatability score was higher for the Prudent
than the Western diet (6.9 ± 1.4 vs 4.7 ± 1.6 out of 10;
P < 0.001), but neither diet was reported to be more
Table 2 Baseline characteristics of participants by diet assignment
Prudent (n = 46) Western (n = 38) P-value
Sex, n (%)a
Male 14 (30.4) 12 (31.6) 1.00
Female 32 (69.6) 26 (68.4)
Ethnicity, n (%)a
White 34 (73.1) 30 (79.0) 0.32
Black/African Canadian 2 (4.4) 0 (0.0)
Asian 8 (17.3) 8 (21.1)
Other 2 (4.4) 0 (0.0)
Age, mean (SD)b 44.1 (19.9) 43.6 (19.1) 0.92
Body weight (kg)b 72.4 (16.3) 69.2 (13.2) 0.32
Height (cm)b 166.7 (8.9) 166.3 (9.4) 0.80
Body-mass index (kg/m2)b 26.1 (5.6) 25.1 (4.5) 0.37
Percent body fat 27.9 (9.0) 28.6 (11.7) 0.72
Waist circumference 80.8 (13.6) 78.0 (12.4) 0.34
Women 79.2 (14.9) 74.2 (11.2) 0.17
Men 84.8 (10.1) 86.6 (11.3) 0.67
Blood pressure (mmHg)
Systolicb 117.6 (17.1) 113.1 (17.9) 0.25
Diastolicb 74.2 (10.5) 73.9 (9.7) 0.87
Lipids (mmol/L)
Total Cholesterolb 4.98 (1.31) 5.30 (1.07) 0.23
HDL-Cb 1.50 (0.40) 1.47 (0.41) 0.72
Women 1.55 (0.36) 1.56 (0.40) 0.97
Men 1.35 (0.44) 1.23 (0.26) 0.40
Non-HDL-Cb 3.48 (1.17) 3.83 (0.94) 0.14
Women 3.64 (1.24) 3.73 (1.03) 0.76
Men 2.98 (0.75) 3.95 (0.73) 0.003
Data are presented as: acounts (% of diet group), bMean (standard deviation)
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palatable than the participants’ pre-study diet. Detailed
symptom diaries were completed by 74 of 84 participants
(88.1 %) at 1 or 2 weeks post-intervention (Table 5). Five
of 35 participants (14.3 %) on the Western and two of 38
participants (5.3 %) on the Prudent diet indicated hunger
(P = 0.25 for between-diets difference), while 2 participants
on the Western diet (2.9 %) reported being uncomfortably
full. Nineteen participants (59.4 %) on the Western and
eleven participants (32.4 %) on the Prudent diet indicated
more gas and/or bloating than usual (P = 0.047 for
between-diets difference). During week 1, those assigned
to the Western diet were more likely to report at least
1 day per week with constipation (12 of 37 [32.4 %]) than
those assigned to the Prudent diet (4 of 45 [8.9 %]). During
week 2, those assigned to the Western diet were also more
likely to report at least 1 day per week with constipation
(9 of 37 [24.3 %]) than those assigned to Prudent (1 of 45
[2.2 %]; P-value for between-diet differences ≤0.01 at both
time points) but there were no changes in frequency of
bowel movements from baseline in either diet.
Participant feedback
At each visit, participants were asked to verbalize their
experiences with the diet during the previous week, with
respect to ease of adherence, overall satisfaction, and
barriers to adherence. After the first week, 35 participants
assigned to the Western diet provided 86 comments; and
44 participants assigned to the Prudent diet provided 73
comments (Additional file 2: Table S3).
The most common negative experiences on the Western
diet related to adverse gastrointestinal symptoms such as
constipation, bloating, diarrhea, cramping or heartburn
(mentioned in 26.7 % of comments); feeling of poor
health, low in “energy”, or lacking mental focus (16.3 %).
The diet itself was described as “not very palatable”
(9.3 %), with “not enough variety” (7.0 %), and “difficult to
stick to” (5.8 %). At the 2-week visit, 45 % of the partici-
pants felt that their adherence and satisfaction with the
diet had improved since the week-1 visit, with 26 % feeling
it was the same, and 7 % noted it was worse. Provision of
less food and more fruits and vegetables were suggestions
participants made to improve the diet.
The most common negative pieces of feedback received
about the Prudent diet were that “too much food was
provided” (17.8 %), “preparation was time-consuming”
(12.3 %), and some negative gastrointestinal symptoms,
such as bloating and constipation (8.2 %). Positive
feedback provided about the Prudent diet was that par-
ticipants felt “healthier”, “full of energy”, and “less
tired” (17.8 %), and experienced better gastrointestinal
function, with easier and more frequent bowel move-
ments (8.2 %). At the 2-week visit, 48 % of the partici-
pants felt that their own adherence and satisfaction
with the diet improved after the first week, with 39 %
feeling it was the same, and 14 % feeling it was worse.
Suggestions provided by participants to improve the
Prudent diet were to provide more detailed recipes,
suggest more flavourful dishes, and reduce the volume
of food provided.
Diet modifications during the study
To improve adherence during the study, small modifica-
tions were made to the diet plans for individuals as neces-
sary. At baseline, one participant requested to substitute
fish products with other foods, and this was accommo-
dated by replacing fish with chicken and lean deli meats.
Three participants (8.5 %) on the Western arm, and three
participants (6.8 %) on the Prudent arm required de-
creases in energy levels to improve adherence or maintain
weight; one participant (2.2 %) on the Prudent diet re-
quested an increase in food to maintain satiety and weight.
Minor requests for changes in the control diet that were
accommodated included drinking less milk (n = 1), having
fewer hamburger patties (n = 1), and switching some of
the carbonated soft drinks for fruit drinks (n = 1). A re-
quest to eat a lean turkey submarine sandwich on whole
wheat bread instead of the prescribed deli meat sandwich
on whole wheat bread (n = 1) was accommodated on the
Prudent arm.
Table 3 Baseline nutrient intake of participants (mean of 7-day
diet histories) by diet assignment
Nutrient Prudent (n = 40) Western (n = 34)
Energy (kcal/d) 2030 (546) 1872 (508)
Total protein (% energy) 17.2 (3.2) 17.9 (3.3)
Available carbohydrate (% energy) 46.6 (8.6) 47.6 (5.9)
Total dietary fiber (g/2000 kcal) 21.9 (7.4) 23.9 (7.8)
Total fat (% energy) 33.8 (6.3) 31.3 (4.3)†
Saturated (% energy) 11.6 (2.9) 10.7 (2.5)
Polyunsaturated (% energy) 5.2 (2.0) 5.0 (1.4)
Monounsaturated (% energy) 10.4 (4.0) 9.2 (2.6)
P:S ratio 0.47 (0.19) 0.49 (0.18)
Dietary cholesterol (mg/2000 kcal) 306 (111) 334 (142)
Alcohol (% energy) 2.8 (3.3) 2.0 (3.1)
Vitamin C (mg/2000 kcal) 93 (52) 102 (46)
Potassium (mg/2000 kcal) 2455 (609) 2529 (694)
Magnesium (mg/2000 kcal) 253 (74) 266 (72)
Sodium (mg/2000 kcal) 2584 (605) 2705 (656)
Vegetables (cup eq./2000 kcal) 1.6 (1.0) 1.8 (0.9)
Fruits (cup eq./2000 kcal) 1.4 (0.9) 1.4 (0.9)
Fruits & Veg (cup eq./2000 kcal) 3.1 (1.4) 3.2 (1.3)
Data are presented as means (SD). Significant between-diet differences are
denoted by † at P < 0.05 (independent samples t-test)
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Body weight
Participants in both groups lost small yet statistically significant
amounts of weight (Prudent, 0.6 kg; P< 0.01 vs. Western,
0.4 kg; P = 0.03), but between-treatment differences were
not significant (P = 0.62). Percent body fat was unchanged
after 2 weeks on the Western Diet, but fell by 1.3 %
(P < 0.01) on the Prudent diet, yielding a significant
between-treatment difference of -1.5 % (P = 0.04).
Changes in serum lipids and blood pressure
The percent changes from baseline to week 2 in total
cholesterol were as follows: In the prudent diet group,
total cholesterol decreased by 3.9 % (P = 0.05), whereas
in the Western diet group, total cholesterol did not de-
cline substantially (+0.6 %; P = 0.69) (Table 6). Change in
total cholesterol over 2 weeks on the Prudent diet was
related to the baseline total cholesterol level (β = -0.143;
P = 0.06), but no such association was seen in the Western
diet (β = -0.035; P = 0.68).
In the Prudent diet group, systolic blood pressure de-
creased by 4 (11) mmHg and diastolic blood pressure fell
by 5 (9) mmHg after 2 weeks (both P < 0.02) (Table 6).
No significant change was observed in the Western diet
group. After adjustment for baseline values, age, and
sex, there was a trend towards lowered systolic blood
pressure (-3.6 mmHg; 95 % CI: -7.8 to 0.7; P = 0.10) and
diastolic blood pressure (-3.0 mmHg; 95 % CI: -6.2 to
0.3; P = 0.07) in the Prudent diet group after 2 weeks,
compared to the Western diet.
Power and sample size estimates
A secondary purpose of our pilot study was to assess the
anticipated sample sizes required for detection of differ-
ences in important CV risk factors in a full-scale trial.
These calculations for low-density lipoprotein-cholesterol
(LDL-C), regional methylation of 9p21, and gene expres-
sion are presented in Additional file 3: Table S2. With 120
participants completing each intervention and control
treatment period in a crossover design, with adjustment
for multiple-testing of 3 pre-specified primary outcomes,
we will have at least 90 % power to detect a 0.75 % differ-
ence in methylation of CDK2NB, and a 10 % difference in
Fig. 1 CONSORT Flow Diagram
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LDL-C. We will have 53 % power to detect a 25 % differ-
ence in gene expression.
Allowance for dropout
Similar published studies with interventions of this type and
duration have reported dropout rates of <10 % [17, 18]. There-
fore, the full scale study would need to enroll 110 participants
per arm. Imputing a change value of “0” for an upper limit of
10 % who dropout, our estimated power will be 86 % for each
of the methylation, LDL-C, and gene expression outcomes.
Discussion
This ‘proof of concept’ randomized controlled feeding
trial confirmed that recruitment of apparently healthy
individuals into a study that provides either a Prudent or
Western diet is feasible and retention is high. Both diets
were reported to be palatable, well tolerated, and small
changes in cardiovascular risk factors (which trended to-
wards statistical significance) and body composition were
seen over a short time period in the Prudent diet.
We were able to recruit our study population over
eight months, through newspaper advertisements, campus
posters, and referrals. During conversations with partici-
pants, the two strongest reasons for participation were
provision of food, and the chance to learn about their gen-
etic risk for cardiovascular disease. Given our recruitment
catchment area (a university campus and surrounding
area) and target population — young, healthy men and
women—it was not surprising that food provision was an
attractive incentive for participation. However, the major-
ity of participants expressed an interest in knowing their
genetic risk for cardiovascular disease, and gaining a better
understanding of how to change their lifestyles to modify
this risk—suggesting that in a highly-educated catchment
area, health education (and possibly “novel” health educa-
tion) is an attractive feature of research study participa-
tion. In our study, participant retention was excellent and
self-reported adherence to the diet plans was high, which
we credit to the short duration of the intervention, and
offering participants flexible options with respect to
how they would obtain their foods for the study.
A first major design consideration was determining
the macro and micronutrient composition of the “Western”
and “Prudent” diets. We attempted to model the “Western”
diet after the typical Canadian macronutrient profile [19],
while retaining elements of well-studied “Western” dietary
patterns [15]. The Western diet contained more satu-
rated fat and less polyunsaturated fat, less fibre, and
Table 4 Nutritional Profiles of Diets Provided and Recorded as
Eaten during the 2 weeks’ intervention by diet assignment
Nutrient Prudent (n = 40) Western (n = 34)
Energy (kcal/d) 2162 (542) 1941 (502)
Total protein (% energy) 18.9 (2.9)‡ 14.4 (1.7)
Available carbohydrate (% energy) 54.0 (3.1)‡ 49.4 (4.2)
Total dietary fiber (g/2000 kcal) 37.8 (5.5)‡ 12.8 (5.3)
Total fat (% energy) 25.6 (3.2)‡ 35.7 (4.4)
Saturated (% energy) 6.3 (1.6)‡ 13.9 (2.4)
Polyunsaturated (% energy) 5.5 (0.7)† 6.2 (1.6)
Monounsaturated (% energy) 11.6 (1.5) 12.0 (1.7)
P:S ratio 0.91 (0.18)‡ 0.46 (0.14)
Dietary cholesterol (mg/2000 kcal) 238 (90)‡ 348 (68)
Alcohol (% energy) 0.9 (1.8) 0.3 (0.8)
Vitamin C (mg/2000 kcal) 256 (53)‡ 79 (55)
Potassium (mg/2000 kcal) 3737 (397)‡ 1864 (563)
Magnesium (mg/2000 kcal) 425 (59)‡ 153 (59)
Sodium (mg/2000 kcal) 1993 (355)‡ 3356 (468)
Vegetables (cup eq./2000 kcal) 3.3 (0.7)‡ 1.1 (0.6)
Fruits (cup eq./2000 kcal) 3.3 (0.8)‡ 0.7 (0.8)
Fruits & Veg (cup eq./2000 kcal) 6.7 (1.4)‡ 1.8 (1.3)
Data are presented as means (SD). Significant between-diet differences are
denoted by † at P < 0.05, or ‡ at P < 0.01 (independent samples t-test)
Table 5 Diet palatability, satiety, and gastrointestinal symptoms experienced on Prudent and Western diets
Prudent diet (n = 33 to 45) Western diet (n = 31 to 45) Mean difference between Prudent and
Western (95 % CI) at 2 weeks
Week 0 Week 1 Week 2 Week 0 Week 1 Week 2
Palatability, mean (SD) (out of 10)a 8.2 (1.5) 6.9 (1.3) 7.1 (1.4) 7.9 (1.3) 4.6 (1.7) 4.8 (1.4) 2.2 (1.6 to 2.9)b§
Satiety (-3 to +3) 1.1 (1.1) 1.3 (1.5) 1.2 (1.1) 0.7 (1.3) 1.0 (1.8) 0.9 (1.2) 0.3 (-0.3 to 0.9)b
Gas/bloating, n (%)
As usual or less than usual 32 (86.5) 26 (76.5) 25 (75.8) 31 (91.2) 22 (62.9) 17 (54.8) 0.047c
More than usual 5 (13.5) 8 (23.5) 8 (24.2) 3 (8.8) 13 (37.1) 14 (45.2)
# bowel movements per week, mean (SD) 7.6 (5.6) 7.5 (6.2) 7.4 (6.1) 6.8 (4.4) 7.0 (4.2) 6.5 (4.7) 0.4 (-1.5 to 2.2)b
Any days of diarrhea, n (%) 4 (4.9) 4 (4.9) 3 (3.7) 1 (1.2) 3 (3.7) 4 (4.9) >0.70c
Any days of constipation, n (%) 5 (6.1) 4 (4.9) 1 (1.2) 2 (2.4) 12 (14.6) 9 (11.0) <0.001c
aWeek 0 is palatability of their usual diet while weeks 1 and 2 reflect the palatability of the intervention diet
bComparison of mean intervention values (week 1 and 2), adjusted for age, sex, and baseline values. Expressed as mean (95 % CI); †P < 0.05, ‡P < 0.01, §P < 0.001
cFisher’s exact test for between-treatment differences in distribution of variables during follow up. Counts of number of participants reporting any days of diarrhea,
constipation, or more bloating/gas in either week 1 or 2 were collapsed for analysis, if such data were also provided at baseline
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more cholesterol than the Prudent diet. The Western
diet was also designed to be lower in vitamin C and po-
tassium, and higher in sodium than the Prudent diet.
No specific targets were set for protein and total carbohy-
drate, but as a function of the foods chosen, the Prudent
diet was higher in protein and total carbohydrate.
A second major design consideration was how to
translate the diets into viable meal options. To do this,
we constructed the “Western” diet around highly proc-
essed foods; and the “Prudent” diet around minimally
processed foods. The resulting nutrient composition was
indicative of an important difference in diet quality. In
the “Western” diet, protein sources were meats such as
beef burgers, fried chicken, and higher-fat deli meats;
carbohydrate sources were refined grains, cereals, and
sweets such as white bread, corn flakes, jelly beans; fat
sources were full-fat dairy, processed cheeses, and butter.
Minimal fruits and vegetables were included, and these
were mostly processed items, such as juices and French
fries. In the Prudent diet, protein sources were lean
meats (e.g., chicken breast), fish (e.g., salmon fillets), and
legumes (e.g., bean salads); carbohydrate sources were
whole grains and fruits such as brown rice, steel-cut oats,
and bananas; fat sources were plant oils such as canola
and olive oils (used in dressings for salads/cooking) and
fish oils occurring in salmon and tuna. A high amount of
fresh fruits and vegetables were provided. People were en-
couraged to use the provided cooking fats for preparation
of meals (e.g. butter for Western; unsaturated oils for Pru-
dent). Cooking suggestions with meal plans were provided,
but flexibility was given so that the participants could pre-
pare the foods as they wished.
A third consideration for this pilot study was deter-
mining the optimal length of the intervention. We chose
2 weeks, as previous reports have shown that changes in
cardiovascular risk factors such as lipids and blood pres-
sure in response to diet modification can be observed
within this time frame [9–12]. Additionally, others have
demonstrated that epigenetic changes in response to
dietary modification can be observed in as little as 5 days
[20]. With these considerations, we deliberately designed
the two diets to be very different (i.e. on extreme ends of
the “healthy eating” spectrum). This between-diet “health-
fulness contrast” was intended to maximize our ability to
see changes in a short time period in apparently healthy
individuals. Furthermore, we had serious reservations
about placing study volunteers on a dietary pattern known
to be detrimental to health (i.e. the “Western” dietary pat-
tern) for longer than 2 weeks. However, feeding trials
which have substantially impacted public health policy
have employed 4- to 6-week feeding periods [12, 21, 22]
and in the planned future trial we will extend our treat-
ment period to 4 weeks. A limitation of this short duration
was that we found it difficult to precisely calibrate pre-
scribed food intake to match energy expenditure, which
resulted in small, but significant weight loss within both
diet groups. In our full-scale trial, we intend to incorporate
a longer run-in period to obtain better estimates of main-
tenance energy requirements that incorporate anthropo-
metric characteristics as well as participants’ usual energy
intakes.
A fourth consideration was whether to provide food
for participants or provide counseling only. We felt
that food provision was the best way to ensure high
adherence to the dietary principles, but our design fell
short of the conventional approach to a controlled
feeding study in a few respects. We were not able to
admit participants for a hospital stay or metabolic ward
for the duration of the study [23], we could not provide
cooked meals for participants [24], and we did not have
the facilities to have participants eat at least 1 meal
per day on site [22]. Notwithstanding these challenges,
provision of food without observation of participant
eating occasions or inpatient admission has been shown
to result in high adherence to dietary advice in settings
similar to ours [21].
Table 6 Effects of Prudent and Western diets on body weight, blood pressure, and lipid risk factors
Prudent (n = 45) Western (n = 37)*
Week 0a Week 2a Changea Week 0a Week 2a Changea Prudent minus Westernb*
Body weight 72.6 (16.4) 72.0 (16.1) -0.6 (1.4)‡ 69.3 (13.3) 68.9 (13.0) -0.4 (1.2)† -0.1 (-0.7 to 0.4)
Body-mass index (kg/m2) 26.1 (5.6) 25.9 (5.4) -0.1 (1.3) 25.1 (4.6) 25.0 (4.4) -0.1 (0.4) -0.02 (-0.44 to 0.40)
Percent body fat 27.9 (9.0) 28.2 (8.5) -1.3 (3.2)‡ 28.6 (11.7) 29.9 (11.3) 0.3 (3.3) -1.5 (-2.9 to -0.04)
Blood pressure (mmHg)
Systolic 118 (17) 114 (16) -4 (11)† 112 (18) 113 (15) 2 (10) -4 (-8 to 1)
Diastolic 74 (10) 70 (10) -5 (9)§ 74 (10) 72 (9) -1 (6) -3 (-6 to 0.3)
Lipids (mmol/L)
Total-Cholesterol 4.92 (1.26) 4.73 (1.24) -0.19 (0.65)† 5.25 (1.05) 5.23 (1.14) 0.03 (0.51) -0.24 (-0.51 to 0.03)
Non-HDL-C 3.43 (1.14) 3.29 (1.13) -0.14 (0.64) 3.81 (0.94) 3.73 (0.99) -0.03 (0.55) -0.15 (-0.42 to 0.12)
Data are presented as aMean (SD) or bmean (95 % CI); *Significance of between-treatment difference in parameter was estimated using analysis of covariance,
adjusted for age, sex, and baseline values. Significant between-diet differences are denoted by †(P < 0.05), ‡(P < 0.01), or §(P < 0.001)
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Participant feedback on the implementation of the
meal plans will be most useful in planning the full trial.
First, though food provision was viewed positively by
participants, the usefulness of this could have been
greatly enhanced if more careful attention was paid to
designing attractive menu items, rather than simple sug-
gestions of which foods to eat at specified times/eating
occasions.
Second, both diets posed challenging for participants
to consume, but for different reasons. The volume of the
foods on the whole-foods, plant-based Prudent diet was
difficult to consume for many participants, and this was
reflected in slightly but significantly lower adherence in
this arm—i.e. less of the prescribed foods were eaten
(e.g. smaller portion sizes of vegetables) or some foods
were omitted (e.g. snacks). The “Western” diet was a
marked departure from usual eating habits for most people,
which we did expect. To help mitigate the anticipated
dissatisfaction with the “Western” diet, we offered diet
counseling with a registered dietitian to all participants
free-of-charge after study completion to help improve
their eating habits. Only one participant took advantage
of this offer.
Third, the preparation time of foods on the Prudent
diet was noted as a major inconvenience for busy students.
While this might be viewed as an expected outcome of a
whole-foods approach to eating, for the purposes of par-
ticipant satisfaction and retention, modifications to the
meal plans may be considered to make the meals easier to
prepare and consume for working/student participants.
These concerns can be addressed in a full-scale trial by
seeking input from not only a dietitian but also a chef to
plan meal suggestions.
Fourth, we learned that the incorporation of some
flexibility into our meal plans will aid adherence, espe-
cially in a full-scale trial of longer duration. In addition
to relatively minor substitutions of food items that can
be made without impacting the spirit of the intended di-
ets (e.g. lean beef for poultry; fast-food turkey submarine
for deli meat sandwiches; fruit or nut exchanges, etc.),
menu plans designed for vegetarian participants or those
with aversions to dairy would increase the number of
eligible participants.
The strengths of our study include (i) full food provision,
which enhanced adherence and allowed for a large contrast
in dietary profiles; (ii) the collection of biological samples
for biochemical, clinical, genetic, and epigenetic assessment
at baseline and post-feeding; and (iii) the choice to have
food delivered using any one of three delivery channels.
The limitations are that (i) the study population was small,
(ii) the duration of the intervention was short (2-weeks),
(iii) we cannot verify that the food provided to the par-
ticipants was actually consumed by the individual en-
rolled in the study (versus being thrown away or eaten
by others in the household), and (iv) we did not have
the facilities to provide any meals on-campus, as is
often done in most feeding studies.
Conclusions
The recruitment of and provision of food to apparently
healthy adults for the purpose of a 2-week intervention
outside of a specialty clinic was well received and had
high retention. A definitive trial powered to detect epigen-
etic changes would be feasible in a similar population, with
some adaptations to the protocol.
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